Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data

Trifluridine/tipiracil increases overall survival (OS) in patients with refractory, metastatic colorectal cancer (mCRC). A post hoc exploratory analysis of the RECOURSE randomized clinical trial (RCT) established two categories, a good prognosis corresponding to subjects having a low tumor burden an...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández Montes, Ana, Carmona-Bayonas, Alberto, Jimenez-Fonseca, Paula, Vázquez Rivera, Francisca, Martinez Lago, Nieves, Covela Rúa, Marta, Cousillas Castiñeiras, Antía, Gonzalez Villarroel, Paula, De la Cámara Gómez, Juan, Méndez, José Carlos Méndez, Carriles Fernández, Carmen, Sanchez Cánovas, Manuel, Garcia García, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275736/
https://www.ncbi.nlm.nih.gov/pubmed/34253805
http://dx.doi.org/10.1038/s41598-021-93732-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275736/
https://www.ncbi.nlm.nih.gov/pubmed/34253805
http://dx.doi.org/10.1038/s41598-021-93732-5

Ejemplares similares